Replies to post #2684 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

Re: PLPro program

There was no announcement, but ENTA removed the PLPro program from the pipeline chart on slide 5 of the latest slide set (https://ir.enanta.com/static-files/0b9a9564-339c-4501-8c98-eab636846bf4 ).

The PLPro program was only in the discovery phase—not yet in preclinical development—and ENTA had not even selected a lead candidate for the program. I.e., very little money has been spent to date on this program. It should be a simple matter for ENTA to reinstate the PLPro program if developments with EDP-235 warrant such an action.